Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 230-249 of 728


The Path to Reading a Newborn’s DNA Mapby Anne EisenbergThe New York TimesFebruary 8th, 2014What if laboratories could run comprehensive DNA tests on infants at birth? Should parents be told of each variation, even if any risk is still unclear? Would they even want to know?
Myriad Settles Gene Patent Lawsuit Against Texas Firmby Tom HarveyThe Salt Lake TribuneFebruary 7th, 2014Myriad Genetics has reached a settlement with Gene by Gene Ltd. and vows to continue legal battles against other competitors trying to jump into the market.
Uzbekistan Is Using Genetic Testing to Find Future Olympiansby Ron Synovitz and Zamira EshanovaThe AtlanticFebruary 6th, 2014The idea of using genetic testing to spot future world-class athletes has been bandied about for years. Uzbekistan is now testing children as young as 10 to determine their athletic potential.
The $1,000 Genome: Game Changer or PR Stunt?by Jessica CussinsBiopolitical TimesFebruary 6th, 2014The DNA sequencing company Illumina announced a new product capable of sequencing an entire human genome for under $1,000. What are the hidden costs? What are the implications of reaching this long-awaited benchmark?
Genetics for the People?by Donna DickensonProject SyndicateFebruary 5th, 2014The rhetoric of personal ownership and control touted by 23andMe hides their flimsy data and actual business plan.
Ethics Questions Arise as Genetic Testing of Embryos Increasesby Gina KolataThe New York TimesFebruary 3rd, 2014The procedure raises unsettling ethical questions that trouble advocates for the disabled and have left some doctors struggling with what they should tell their patients.
Genetic Determinism: Why we Never Learn — And Why it Mattersby Nathaniel ComfortGenotopiaJanuary 29th, 2014Studying the history of genetics and popularization has led me to the surprising conclusion that genetic oversell is independent of genetic knowledge. We see the same sorts of articles in 2014 as we saw in 1914.
How FDA and 23andMe Dance Around Evidence That Is Not Thereby Cecile JanssensHuffington PostJanuary 27th, 2014Almost all former direct-to-consumer genetic testing companies have closed up shop. In the wake of criticism from all sides will 23andMe be next?
Right on target: New era of fast genetic engineeringby Colin BarrasNew ScientistJanuary 27th, 2014If we ever decide to genetically modify people, this is the tool to do it with.
California’s stem cell agency poised to bet big on genomics researchby David JensenSacramento BeeJanuary 26th, 2014Directors of the California stem cell agency are preparing to create one or two stem cell genomic centers that they predict will make the state a world leader in the new field.
A genetic “Minority Report”: How corporate DNA testing could put us at riskby Benjamin WinterhalterSalonJanuary 26th, 201423andMe's FDA problems are just the beginning - the company's DNA tests open up a wealth of privacy concerns.
Is genius in the genes?by Steven RoseTESJanuary 24th, 2014The debate about genes and intelligence has resurfaced, and it’s more fervent than ever. Can achievement truly be inherited? Should education be tailored to individuals’ genetic potential?
Soaring sales of 'dangerous' do-it-yourself DNA test kits: Number of websites selling products doubles in two yearsby Sean PoulterDaily Mail (UK)January 20th, 2014Sales of DNA tests for everything from the risk of developing life-threatening diseases to catching out cheating partners are booming, though many scientists suggest that DIY home DNA testing could cause real harm.
Hit-and-Miss Genetic Testingby Pete ShanksBiopolitical TimesJanuary 20th, 2014In at least four experiments, identical DNA has been sent to different direct-to-consumer testing companies. In every case, significant anomalies appeared.
Google, Tell Me. Is My Son a Genius?by Seth Stephens-DavidowitzNew York TimesJanuary 18th, 2014Google searches suggest that American parents are far more likely to want their boys smart and their girls skinny. Among those looking for information on sex selection, there is about a 10 percent preference for boys.
There’s a Gene for Thatby Pankaj MehtaJacobinJanuary 18th, 2014History is littered with horrifying examples of the misuse of evolutionary theory to justify power and inequality. Welcome to a new age of biological determinism.
The FDA Is Not Anti-Geneticsby Michael WhitePacific StandardJanuary 17th, 2014Despite the recent crackdown on 23andMe, the FDA is engaging with fast-moving biotechnology advances. However, there’s still much work to be done.
FDA approves genetic test that screens infants for predictors of mental disabilitiesby Matthew PerroneAssociated PressJanuary 17th, 2014The laboratory test from Affymetrix detects variations in patients' chromosomes that are linked to Down syndrome, DiGeorge syndrome and other developmental disorders.
Aiming to Push Genomics Forward in New Studyby Andrew PollackNew York TimesJanuary 13th, 2014Regeneron Pharmaceuticals, a fast-growing biotech company, is undertaking an ambitious new genomics effort with a health care provider that treats 3 million people in Pennsylvania.
Testing times for the consumer genetics revolutionby Donna DickensonNew ScientistJanuary 13th, 2014With the highest-profile seller of $99 genetic tests under fire, will public trust in personalised medicine suffer?
Displaying 230-249 of 728  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760